Development of the clinical next-generation sequencing industry in a shifting policy climate

Nat Biotechnol. 2014 Oct;32(10):980-2. doi: 10.1038/nbt.3030.

Authors

Margaret A Curnutte¹, Karen L Frumovitz¹, Juli M Bollinger², Amy L McGuire¹, David J Kaufman²

Affiliations

¹ Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, Texas, USA.
² Genetics and Public Policy Center, Berman Institute of Bioethics, Johns Hopkins University, Washington, DC, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Biotechnology* / legislation & jurisprudence
Biotechnology* / organization & administration
Biotechnology* / trends
Genomics* / legislation & jurisprudence
Genomics* / organization & administration
Genomics* / trends
High-Throughput Nucleotide Sequencing / trends*
Humans

Grants and funding